Togo
Diabetes country report 2000 — 2050
Number of adults (20–79 years) with diabetes in Togo (TG)
2000 | 9.6 thousand |
2011 | 81.2 thousand |
2024 | 177.5 thousand |
2050 | 397.3 thousand |
Togo is one of the 49 countries and territories in the IDF Africa Region.
Data source(s) used for the diabetes estimates in adults:
- Estimates extrapolated from Benin, Cabo Verde, Gambia, Ghana, Liberia, Niger, Nigeria and Senegal.
Diabetes estimates (20-79 y) | ||||
---|---|---|---|---|
People with diabetes, in 1,000s | 9.6 | 81.2 | 177.5 | 397.3 |
Age-standardised prevalence of diabetes, % | - | 3.3 | 4.8 | 5.6 |
Proportion of people with undiagnosed diabetes, % | - | - | 80.1 | - |
People with undiagnosed diabetes, in 1,000s | - | - | 142.2 | - |
Impaired Fasting Glucose (IFG) | ||||
---|---|---|---|---|
People with IFG, in 1,000s | - | - | 352.2 | 764.7 |
Age-standardised prevalence of IFG, % | - | - | 7.7 | 8.7 |
Impaired Glucose Tolerance (IGT) | ||||
---|---|---|---|---|
People with IGT, in 1,000s | - | 327.1 | 409.9 | 835.5 |
Age-standardised prevalence of IGT, % | - | 11.8 | 9.5 | 9.9 |
Mortality attributable to diabetes (20-79 y) | ||||
---|---|---|---|---|
Deaths attributable to diabetes | - | 6,928.0 | 1,513.8 | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 3.5 | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
---|---|---|---|---|
Live births affected by HIP | - | - | - | - |
Prevalence of gestational diabetes mellitus (GDM), % | - | - | - | - |
Live births affected by other types of diabetes first detected in pregnancy | - | - | - | - |
Live births affected by other types of diabetes detected prior to pregnancy | - | - | - | - |
Diabetes-related health expenditure | ||||
---|---|---|---|---|
Total diabetes-related health expenditure, USD million | - | - | 31.0 | 66.2 |
Total diabetes-related health expenditure, ID million | - | - | 81.1 | 173.0 |
Diabetes-related health expenditure per person, USD | - | 67.0 | 174.8 | 166.5 |
Diabetes-related health expenditure per person, ID | - | - | 456.8 | 435.3 |
Type 1 diabetes estimates in children and adolescents | ||||
---|---|---|---|---|
People with type 1 diabetes (all age groups) | - | - | 696.0 | - |
People with type 1 diabetes (0-19 y) | - | - | 187.4 | - |
Demographics | ||||
---|---|---|---|---|
Total adult population (20-79 y), in 1,000s | 1,991.0 | 3,037.3 | 4,613.8 | 8,851.1 |
Population of children and adolescents (0-19 y) | - | - | 4,769,147.5 | - |
Diabetes estimates (20-79 y) | |
---|---|
People with diabetes, in 1,000s | 9.6 |
Age-standardised prevalence of diabetes, % | - |
Proportion of people with undiagnosed diabetes, % | - |
People with undiagnosed diabetes, in 1,000s | - |
Impaired Fasting Glucose (IFG) | |
---|---|
People with IFG, in 1,000s | - |
Age-standardised prevalence of IFG, % | - |
Impaired Glucose Tolerance (IGT) | |
---|---|
People with IGT, in 1,000s | - |
Age-standardised prevalence of IGT, % | - |
Mortality attributable to diabetes (20-79 y) | |
---|---|
Deaths attributable to diabetes | - |
Proportion of diabetes-related deaths in people 20-79 y, % | - |
Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
---|---|
Live births affected by HIP | - |
Prevalence of gestational diabetes mellitus (GDM), % | - |
Live births affected by other types of diabetes first detected in pregnancy | - |
Live births affected by other types of diabetes detected prior to pregnancy | - |
Diabetes-related health expenditure | |
---|---|
Total diabetes-related health expenditure, USD million | - |
Total diabetes-related health expenditure, ID million | - |
Diabetes-related health expenditure per person, USD | - |
Diabetes-related health expenditure per person, ID | - |
Type 1 diabetes estimates in children and adolescents | |
---|---|
People with type 1 diabetes (all age groups) | - |
People with type 1 diabetes (0-19 y) | - |
Demographics | |
---|---|
Total adult population (20-79 y), in 1,000s | 1,991.0 |
Population of children and adolescents (0-19 y) | - |